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Abstract  
The phosphatase PHOSPHO1 is involved in the initiation of 
biomineralisation. Bones in Phospho1 KO mice show histological 
osteomalacia with frequent bowing of long bones and spontaneous fractures: 
they contain less mineral, with smaller mineral crystals. However, the 
consequences of Phospho1 ablation on the microscale structure of bone are 
not yet fully elucidated. Tibias and femurs obtained from wild-type and 
Phospho1 null (KO) mice (25-32 week-old) were embedded in PMMA, cut 
and polished to produce near longitudinal sections. Block surfaces were 
studied using 20kV backscattered-electron (BSE) imaging, and again after 
iodine staining to reveal non-mineralised matrix and cellular components.  For 
3D characterisation, we used x-ray microtomography. Bones opened with 
carbide milling tools to expose endosteal surfaces were macerated using an 
alkaline bacterial pronase enzyme detergent, 5% hydrogen peroxide and 7% 
sodium hypochlorite solutions to produce 3D surfaces for study with 3D BSE 
scanning electron microscopy. Extensive regions of both compact cortical and 
trabecular bone matrix in Phospho1 KO mice contained no significant mineral 
and/or showed arrested mineralisation fronts, characterised by a failure in the 
fusion of the calcospherite-like, separately mineralising, individual micro-
volumes within bone. Osteoclastic resorption of the uncalcified matrix in 
Phospho1 KO mice was attenuated compared with surrounding normally-
mineralised bone. The extent and position of this aberrant biomineralisation 
varied considerably between animals, contralateral limbs and anatomical sites. 
The most frequent manifestation lay, however, in the nearly complete failure 
of mineralisation in the bone surrounding the numerous transverse blood 
vessel canals in the cortices.  
In conclusion, SEM disclosed defective mineralising fronts and extensive 
patchy osteomalacia, which has previously not been recognised. These data 
further confirm the role of this phosphatase in physiological skeletal 
mineralisation. 
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Introduction 
Bone formation depends on an integration of events orchestrated by the 
capacity of osteoblasts to synthesise, secrete and mineralise bone’s 
extracellular matrix (ECM). This cascade of events which culminates in 
mineral deposition in collagen (biomineralisation), is critical to skeletal 
structure, integrity and function throughout life (Kawasaki et al., 2009). 
PHOSPHO1, a member of the haloacid dehalogenase superfamily, is highly 
expressed in bone and contributes to bone mineralisation through its 
participation in the formation of the initial hydroxyapatite seed crystals 
(Stewart et al., 2003, 2006, Roberts et al., 2007, Houston et al., 1999, 2004) . 
Treatment of developing chick embryos with lansoprazole, a small molecule 
that inhibits PHOSPHO1, completely inhibited mineralisation of all long 
bones (Macrae et al., 2010).  Furthermore, bones from Phospho1 KO mice 
accumulate mineral poorly, leading to less stiff and more ductile bones in 
young juvenile mice (Huesa et al., 2011, Carriero et al., 2014, Rodriguez-
Florez et al., 2015). This more compliant bone is consistent with the relative 
protection of long bones from Phospho1 KO mice against fracture during 3-
point bending (Huesa et al., 2011). Also, the greater deformability is also 
consistent with the multiple skeletal abnormalities described in Phospho1 KO 
mice which include osteomalacia, bowing of long bones and sporadic 
spontaneous fractures exhibiting a predominantly greenstick presentation 
(Yadav et al., 2011). Interestingly, this greater bone deformability appears to 
resolve in adult mice where the degree of stiffness in the Phospho1 KO bones 
was corrected upon attainment of skeletal maturity (Javaheri et al., 2015). It is 
therefore likely that the optimal actions of PHOSPHO1 are most pronounced 
during rapid and timely ECM mineralisation in the early development of the 
skeleton, and that this contribution can be effectively mimicked by alternative 
mechanisms in later life (Millan, 2013, Yadav et al., 2016).  
Studies by Yadav et al (2011) have examined whether overexpression of tissue 
non-specific alkaline phosphatase (TNAP) can effectively prevent the 
development of skeletal abnormalities in Phospho1 KO mice. They found that 
TNAP overexpression offered no apparent protection against the deleterious 
bone phenotype that develops in Phospho1 KO mice despite the correction of 
plasma pyrophosphate (PPi) levels - a potent inhibitor of ECM mineralisation  
(Meyer, 1984) - in these mice. This suggests that PHOSPHO1 and TNAP have 
non redundant functional roles during skeletal mineralisation. This is 
emphasised by the deletion of a single allele of Alpl in the Phospho1 null 
background, which was found to aggravate the skeletal phenotype of 
Phospho1 KO mice whereas there was a complete absence of skeletal 
mineralisation in embryonic mice with a double ablation of Phospho1 and 
Alpl function (Yadav et al., 2011). 
In spite of this growing awareness of the contribution made by PHOSPHO1 to 
biomineralisation, our knowledge is mainly limited to observations made at 
the whole bone level (macroscale) where valuable information on bone 
structure and biomechanical properties of Phospho1 KO mice have been 
reported. In contrast, the importance of PHOSPHO1’s contribution to bone 
mineralisation at the micron resolution scale has been less well addressed.  
The aim of this present study was therefore to perform a mainly scanning 
electron microscopic (SEM) based analysis of Phospho1 KO bones to further 
clarify the function of this intracellular/intravesicular phosphatase in 
biomineralisation. 
Materials and methods 
Animal model 
Phospho1-R74X-null mutant (Phospho1 KO) mice were generated by N-
ethyl-N-nitrosourea mutagenesis (ENU) as described previously (Yadav et al., 
2011). Mice were housed up to 4 per cage in polypropylene cages with wood 
chip and paper bedding and provided standard mouse chow and water ad 
libitum throughout the study. Weaners up to 8 weeks of age were fed a 
standard rodent breeding diet and thereafter a standard rodent maintenance 
diet (Special Diet Services, South Witham, UK).  All procedures complied 
with the UK Animals (Scientific Procedures) Act 1986 and were reviewed and 
approved by the ethics committee of The Roslin Institute, University of 
Edinburgh. 
PMMA embedding 
Tibias and femurs from C57BL6 wild-type (WT) and Phospho1 KO male 
mice (25 – 32 week-old) were fixed in formaldehyde for 48 hours, dehydrated 
in ethanol; substituted with xylene; infiltrated in pure methyl methacrylate 
monomer; then with monomer catalysed with α-azo-iso-butyronitrile at room 
temperature until rubbery; then finally hardened at 37°C.  The PMMA blocks 
were cut and polished to produce near longitudinal sections. 
Backscattered Electron (BSE) SEM imaging (Fig 1A) 
Uncoated PMMA blocks were imaged using 20kV backscattered electron 
(BSE) imaging at 50Pa pressure in a Zeiss EVO MA10 SEM (Zeiss, 
Cambridge, UK). To determine whether there were obvious differences in the 
degree of mineralisation in bone in WT and Phospho1 KO mice, matching 
fields were imaged at identical sample-to-detector distances in quick sequence 
under stable instrument operating conditions.   
BSE SEM imaging of triiodide stained PMMA block surfaces (Fig1B, 2A-D, 
Fig 3A&B) 
To further characterise the histology of WT and Phospho1 KO bones, block 
surfaces were stained with ammonium tri-iodide  to reveal non-mineralised 
matrix (such as osteoid) and cellular components before further BSE SEM 
(Boyde, 2012b). 
Maceration using Tergazyme™ and Hydrogen Peroxide (Fig 4A-E) 
To remove the cells and superficial non-mineralised collagen, we opened 70% 
ethanol fixed bones with carbide milling tools to expose the endosteal 
surfaces, which were then macerated with alkaline bacterial pronase 
(Tergazyme ™ , Alcanox, New York, NY: Boyde, 2012a) at  50oC and 5% 
H2O2 at room temperature.  The samples were subsequently washed, 
dehydrated in ethanol and air-dried to produce uncoated surfaces for study 
with 3D 20kV BSE SEM, again at ~50Pa chamber pressure. 
X-ray microtomography (XMT) (Fig3C) 
For additional 3D characterisation, we used XMT (1172 x-ray 
microtomograph, Skyscan, Belgium).  Bones from male WT and Phospho1 
KO mice were fixed in 70% EtOH and stored until scanning, with X-ray tube 
operated at 50 kV and 200 μA1600 ms exposure time with a 0.5 mm 
aluminium filter, voxel size 5µm, 0.6° rotation angle, 2 frame averaging, of 
whole bones before embedding in PMMA. Trimmed PMMA blocks were 
scanned again after SEM imaging 3D, when rendering was performed using 
Drishti software (Australian National University, Canberra: Fig 3C). 
Preparation of 10 micron ground section from SEM block face (Fig 3D-Ff) 
In one instance, a ten micron thick ground section of a Phospho1 KO block 
face studied by BSE SEM both before and after iodine staining and after XMT 
was prepared. The block face was glued to a 1mm thick glass slide with 
cyano-acrylate adhesive. A 1030nm laser operated in pulsed mode to give 
tissue ablation, was used to cut the block at ~15 µm into the tissue 
(‘TissueSurgeon’, Rowiak GmbH, Hannover, Germany), the surface then 
being finished by gentle polishing on 4000 grade silicon carbide polishing 
paper. The section was mounted using glycerine, studied by plane polarised 
light microscopy (Fig 3D), and further stained with MacNeal’s tetrachrome 
(Fig 3E: George T Gurr, London, UK), and acridine red (Fig 3F: Gurr) for 
conventional transmitted light microscopy. 
Further SEM studies (Figs 5A-D & 6A,B) 
After initial rounds of SEM study, many samples were re-prepared and re-
examined by SEM. Some samples which had been macerated with Tergazyme 
and H2O2 were further treated with 5% available chlorine sodium hypochlorite 
(bleach) solutions, a more rigorous and vigorous method of removing non-
mineralised collagenous matrices (Fig5A-D).  
In some cases the bone was first remilled to provide better exposure of 
endosteal surfaces where these had been partially obscured in the initial 
preparation round. PMMA block surfaces were etched with an acid gel (Icon-
Etch, DMG, Hamburg, Germany) followed by removal of demineralised 
matrix with sodium hypochlorite solution to leave surface casts of PMMA 
embedded space (Figs 6A&B). Some samples which had been macerated as 
above were embedded in PMMA and block faces polished as above 
(Supplementary Figs 6C&D).  
Results  
BSE imaging of PMMA block faces revealed extensive regions of compact, 
cortical bone matrix in Phospho1 KO mice which contained no significant 
mineral and showed arrested mineralisation fronts. This arrest - not observed 
in any of the WT control bones studied - was demonstrated by the failure of 
fusion of the separately mineralising micro-volumes (Fig. 1A).  
We therefore stained the samples with iodine or tri-iodide to reveal non-
mineralised matrix and cellular components, which highlighted the 
distribution of non-mineralised matrix (osteoid). Elliptical patches of 
mineralised matrix were regularly seen within the regions of non-mineralised 
matrix close to the otherwise mineralised matrix of Phospho1 KO mice (Figs 
1B; 2A-C; 3A,B; 6A).  
Attempts to explore whether this patchy, arrested mineralisation occurred 
reproducibly at specific anatomical locations, demonstrated instead that the 
extent and position varied considerably between animals, contralateral limbs 
and anatomical sites. There was also great variation in the size of the non-
mineralised matrix areas, which ranged from zones approximately 50µm 
across that were centred around the blood vessel canals in the cortex, to the 
largest patches which extended to the millimetre scale (Figs 1A,B; 2A-C; 3A-
F). The vascular channel associated deficiency appears to be the most frequent 
manifestation of defective biomineralisation in the Phospho1 KO mice (Fig 
2A,B). Neither was ever observed in WT bones (Fig 2D).  
In order to more precisely define the biomineralisation deficit, we selected a 
single location from BSE SEM imaging of iodine stained PMMA block 
surfaces that we could readily identify and thus examine at a range of scales, 
using several methodologies (Fig. 3). By XMT, we were unable to 
discriminate PMMA as such from PMMA embedded uncalcified bone and 
cartilage, or tendon and ligament, or bone marrow space. The non-mineralised 
matrix regions in bone therefore appeared as ‘empty’ space (Fig 3C, see also 
supplementary Fig7 and video submitted for supplementary documentation), 
but nevertheless allowed spatial equivalence to be registered in the images of 
the entire bone segment.  
Polarised light examination of a ground section of the bone block-face 
prepared by dual photon laser ablation and at the boundary between non-
mineralised cortex and mineralised bone in these Phospho1 KO mice revealed 
clear continuity of lamellae from mineralised to non-mineralised regions (Fig 
3D).  
Tetrachrome (blue-green in Fig 3E) or acridine red (pale purple, Fig 3F) 
staining of this patch of non-mineralised tissue in Phospho1 KO mice was 
positive and resembled the staining colour and intensity observed in non-
mineralised regions of osteoid found as expected elsewhere at forming bone 
surfaces. It is noteworthy, that osteocytes were present in the abnormal osteoid 
patches as seen both by iodine stained SEM of block faces and light 
microscopy (Fig 3B,E,F). 
To visualise the calcified bone proper, we removed both cells and non-
mineralised collagen with Tergazyme and H2O2 (Fig. 4). The mineralised 
matrices of the inorganic tissues were analysed following such ‘maceration’ 
by 3D BSE SEM morphological imaging (Boyde, 2012a). As some non-
mineralised matrix osteoid remained after Tergazyme and H2O2 cleaning, we 
treated some samples additionally with sodium hypochlorite bleach (Fig. 5). 
This removed non-mineralised matrix remnants leaving a cleaner mineral 
front, making it easier to survey periosteal bone surfaces where fibrous 
periosteum, tendon or ligament residues are more difficult to remove. 
Bones from Phospho1 KO mice after Tergazyme and H2O2  cleaning exhibited 
extensive areas of osteoid and abnormal, arrested or defective mineralisation 
fronts on both the endosteal (Figs 4A-D) and periosteal  surfaces of the cortex 
and on trabeculae (Suppl. Figs. 4G & H). The WT control bones revealed 
endosteal surface with resorbed patches and fully mineralised (smooth) 
regions (Fig. 4E, Suppl. Fig 4F).   
The arrested or impeded collagen-fibre-bundle centred mineralisation in the 
Phospho1 KO bones is indicative of osteomalacia. The observed hints of 
attenuation of osteoclastic resorption at the edges of uncalcified matrix 
patches in Phospho1 KO bones (Fig 4D, 5A) is in line with the widely 
accepted understanding that osteoclasts hunt for mineral. 
All macerated and bleached samples revealed very obvious areas of abnormal 
mineralisation fronts on trabecular bone which can be clearly demarcated 
from regions of osteoclastic resorption (Fig 5A, see also Supplementary Fig 
6F&G). This clear demarcation was also observed on endosteal surfaces (Fig 
5B) reinforcing the observation that aberrant mineralisation in Phospho1 KO 
mice attenuates resorption compared with surrounding normally-mineralised 
bone (Fig 5A&B). This treatment also accentuated the failure of 
mineralisation in the bone, surrounding blood vessel canals in the cortices, 
where separately mineralised micro-volumes were very obvious. The 
individual, calcospherite-like micro-volumes could be seen to be multiply-
penetrated by osteocyte canaliculi (Fig 5C&D; see also Supplementary Fig 
6C).  
Abnormal mineralising fronts were encountered much less frequently at 
periosteal surfaces, in keeping with the fact that it is the endosteal surfaces in 
both distal femur and proximal tibia that are largely formative, whilst 
periosteal surfaces show a higher incidence of resorbing or resting regions 
(Enlow, 1962).   
Finally, we have used PMMA-embedded material that had subsequently been 
etched with acid and bleach, to expose the non-mineralised regions ‘proud’ as 
a surface elevations and thus reveal the extent of the non-mineralised patches 
of bone in Phospho1 KO mice in 3D. SEM of these etched PMMA blocks 
confirmed the extension of this non-mineralised bone into regions within the 
cortical bone of these Phospho1KO mice and also provide scope to visualise 
the osteocyte content of both the non-mineralised patch of bone and the 
normally mineralised neighbouring cortices (Fig 6A,B).   
Discussion 
Osteomalacia is often characterised by broad bands of osteoid with partial or 
complete failure of calcification; a phenotype that has been observed 
previously in Phospho1 KO mice where the osteoid volume fraction is 
significantly increased (Yadav et al., 2011, 2014, 2016).  The new data 
presented here suggests that the osteomalacia present in Phospho1 deficiency 
may be locally more severe than previously reported and yet be clearly 
delineated with an abrupt transition. Furthermore, previous studies of the 
endosteal surface of many genetically modified mice with defective bone 
mineralisation phenotypes had, as yet, never revealed the distinctive type of 
defective mineralisation observed in the Phospho1 KO mice. This suggests to 
us that the patchy osteomalacia noted in the Phospho1 KO mice is not a 
general skeletal hallmark of hypomineralisation but is, as yet, rather a specific 
consequence of Phospho1 deficiency.  
The present observations were unexpected and it is difficult to fully reconcile 
the presence of the stochastically-distributed, relatively large patches of non-
mineralised matrix with our present understanding of how PHOSPHO1 
initiates the nucleation of bone mineral (Millan, 2013).Since the bone 
phenotype of Phospho1 KO mice was first described, efforts have been 
focussed on elucidating the mechanisms by which PHOSPHO1 contributes to 
skeletal mineralisation. Systemic levels of calcium and phosphate are normal 
in Phospho1 KO mice and therefore the defect in bone mineralisation is likely 
to be at the cellular level (Yadav et al., 2011). A possible mechanism may 
involve the potent calcification inhibitors, PPi, and osteopontin (OPN, 
encoded by the Spp1 gene) whose plasma and  bone expression levels are both 
elevated in Phospho1 KO mice (Meyer 1984, Speer et al. 2002, Steitz et al. 
2002,  Yadav et al, 2011, 2014).   However, reducing the PPi levels in 
Phospho1 KO mice by cross breeding them to a transgenic strain expressing 
human TNAP under control of the ApoE promoter, did not improve the 
skeletal phenotype of Phospho1 KO mice (Yadav et al. 2011). In contrast,  the 
development of the skeletal phenotype of Phospho1 KO mice is prevented by 
the ablation of Spp1 function and establishes a primary role for OPN, rather 
than PPi, in the aetiology of the osteomalcia observed in the Phospho1 KO 
mice (Yadav et al. 2014).  
Further efforts have centred on an early observation that PHOSPHO1 is 
present and active within matrix vesicles (MVs) where it may have a role in 
scavenging inorganic phosphate from MV membrane phospholipids 
(phosphocholine and phosphoethanolamine) to favour intra-vesicular 
hydroxyapatite deposition (Roberts et al., 2004, Stewart et al., 2006). Atomic 
force microscopy and Raman spectroscopy analyses have shown that 
chondrocyte-derived MVs from Phospho1 KO mice have a decreased ability 
to initiate mineralisation (Yadav et al., 2016). These data extend our previous 
observations on mice KO in both Phospho1 and AlPl. Although embryonic 
lethal, the embryos show a complete absence of skeletal mineralisation and 
MVs devoid of mineral (Yadav et al., 2011).   
Immature woven bone, like peripheral or mantle dentine, normally contains 
large numbers of  MVs and the mineralisation pattern shows large numbers of 
small, separate microcalcospherites (Boyde, 1980a,b; 2012a). The slowly 
formed lamellar bone in large bones in adult large mammals (including man) 
contains few, if any, MVs: the mineralisation process occurs instead by 
spreading through the collagen fibre bundles of the bone matrix giving rise to 
the very characteristic collagen-bundled centred mineralisation front pattern 
seen in anorganic (deproteinised) preparations for SEM (Boyde, 1980a,b, 
2012a). On the other hand, the rapidly formed lamellar bone in small rodents 
shows a much larger number of separate centres, and it is much more difficult 
to visualise the collagen layout in the matrix in the mineralising ‘front’. This 
would suggest that there are indeed large numbers of MVs.  Then it becomes 
clear that MVs devoid of PHOSPHO1 will result in the observed 
mineralisation pattern demonstrated here, but why the distribution of this 
osteomalacia is patchy is unclear.  One possible explanation is that 
PHOSPHO1 plays a much more subtle and pivotal role at the inception phase 
of mineralisation than previously considered. We propose that the 
mineralisation deficiency conferred by PHOSPHO1 deletion is initially 
insurmountable, mostly at certain locations, where rapid rates of 
mineralisation are otherwise unconstrained, and are thus centred 
predominantly at endosteal and innermost perivascular surfaces.  Long-term 
recovery from such patchy osteomalacia in the more mature adult skeleton 
would therefore imply that this PHOSPHO1 function can eventually be 
overcome by potentially diverse,  slower-acting mineralisation mechanisms. 
Alternative proposed mechanisms for mineral nucleation include the 
precipitation and propagation of mineral crystals in the gap zone of collagen 
fibrils (Glimcher, 1987, Landis et al., 1993, Landis and Jacquet, 2013, 
Nudelman et al., 2010). Alternatively, electron microscopy and X-ray 
diffraction studies on human cortical bone, have led others to propose that the 
majority of mineral is present outside of collagen fibrils and in the 
interfibrillar compartment, in the form of elongated mineral plate structures 
(McNally et al., 2012, McNally et al., 2013, Schwarcz et al., 2014).  The 
results of ion beam thinning to prepare hard tissue sections for TEM have 
been interpreted as showing that mineral enwraps the collagen microfibril and 
is therefore within the fibril but topologically outside the (tropo)collagen 
molecules, the mineral phase being present as extremely long features 
unrelated to the gap zone  (Boyde, 1974, Boyde and Pawley, 1976). This 
further explains why anorganic bone samples, such as those prepared by 
prolonged hypochlorite treatment, do not fall apart to make a suspension of 
fine crystals. Instead they permit us to study the mineralisation phenomena in 
3D objects, as in several of the figures in this paper.  
A novel concept that mineral may enter osteoid collagen as ready-packaged 
globules of disordered calcium phosphate (Mahamid et al., 2011; Kerschnitzki 
et al., 2016a,b) - perhaps with carbonate enrichment at initial mineral cluster 
sites (Nitiputri et al, 2016) - does not contribute to explaining the patchy 
nature of the histological osteomalacia which is the focus of the present 
report. 
PHOSPHO1 deficiency has been suggested to significantly increase osteocyte 
lacunae density and vascular content of cortical bone (Javaheri et al., 2015). 
These conclusions could, however, be explained by the present findings using 
higher resolution imaging as follows: the vascular canals are very frequently 
contained within the more numerous and smaller unmineralised matrix 
regions we reveal here. We show that osteoid cannot be distinguished from 
canal space by XMT, and the canals will therefore appear to be larger and to 
occupy a larger volume fraction. If there were, in addition, a thin seam of 
unmineralised matrix around some of the osteocyte lacunae – as is known to 
be the case in several instances of osteomalacia (Boyde, 1980a,b) - then  the 
lacunae will be more effectively detected by XMT - the more so the better the 
resolution and Javaheri et al. (2015) employed 0.6µm - and the count will 
increase, as well as the volume fraction.   
The 3D extent of these non-mineralised regions can be seen in XMT image 
sequences (Suppl. Figure 7 and video). XMT resolution is inadequate in 
discriminating focal mineralisation defects from vascular/ lacunar-canalicular 
changes, but XMT has the advantage of maintaining the sample whole. Co-
registration of images from both modalities discloses very effective co-
localisation of the areas of bone matrix devoid of mineral and highlight the 
relatively random targeting of osteomalacia in the cortical bone. The patchy 
dissemination of the most severe type of lesion is a reminiscent of the mosaic 
distribution of lesions seen in fibrous dysplasia (Saggio et al., 2014). The 
present results with those shown earlier also disclose that osteocytogenesis 
seems to continue relatively unabated in the bones of Phospho1 KO mice, 
including in the totally unmineralised osteoid regions, yet some cell culture 
and in vivo studies have previously suggested that ECM mineralisation is an 
essential regulator of osteocytogenesis (Irie et al., 2008, Prideaux et al., 2012). 
In conclusion, this study revealed the consequences of Phospho1 deficiency 
on the microscale structure of mineralised bone. SEM disclosed defective 
mineralising fronts and extensive histological osteomalacia which was most 
frequent in bone surrounding the numerous transverse blood vessel canals in 
the cortices. This extensive - but patchy or spotty - histological osteomalacia 
found in Phospho1 KO lower limb bones has previously not been recognised 
and these data further confirm the necessity of this phosphatase for 
physiological mineralisation and the establishment of proper skeletal 
structure.  
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Captions to illustrations. 
Figure 1, 2 parts, Column width. Before and after ammonium triodide 
staining. 
Figure 1A.  BSE of  tibial cortex from Phospho1 KO mouse showing one 
very large and several smaller patches of non-mineralised bone matrix, i.e., 
osteoid.  Section plane is a tangent to the external surface. All SEM images 
were recorded from uncoated samples, Zeiss EVO MA10 SEM, 20kV, with 
50Pa chamber pressure to prevent electrostatic charging.  
Figure 1B.  Part of same region as Fig 1a after ammonium triodide staining to 
reveal non-mineralised matrix and cellular components. Arrows show patches 
of mineralised matrix within the background of non-mineralised matrix 
osteoid and along the arrested mineralising front.  
Figure 2, 4 parts, page width, i.e., a ‘Plate’. All parts ammonium tri-
iodide stained to reveal soft tissue components. 
Figure 2A. KO. Proximal tibia showing many patches of mineralised matrix 
within areas of non-mineralised matrix osteoid  (white arrows).  
Figure 2B. KO. Tibial diaphysis. White arrows show osteoid patches  at 
endosteal, marrow surface. Black arrows show variation in the size of osteoid 
areas (down to zones 20 - 50µm across) centred on the blood vessel canals in 
the cortex.   
Figure 2C. KO.  Knee. Dense fibrous connective tissue of periosteum at 
white arrows, not to be confused with osteoid areas in cortex at black arrows. 
Figure 2D. WT control knee, same scale.  
Figure 3, 6 parts, page width, i.e., a ‘Plate’. 
Figure 3A-F. Correlation of block face BSE SEM, XMT and PLM and 
LM. Asterix shows same spot in each part.  
Figure 3A. KO tibia. BSE SEM of  ammonium tri-iodide stained block face 
to reveal non-mineralised matrix osteoid and cellular components. Black 
arrow points to large osteoid patch. (After SEM studies we cut the blocks to 
make smaller samples for high resolution XMT).   
Figure 3B. Higher magnification view of large and small osteoid patches. 
Blood vessel canals are arrowed (black in bone and white in osteoid). Asterix 
shows spot similarly marked in Fig 3c-f.   
Figure 3C. Drishti reconstruction of XMT data. The large osteoid patch  seen 
in Figs 3a & B show as void (white horizontal arrow)  in the rendered XMT 
Image. This is in same position as black arrow in Fig 3A.. 
Figure 3D. ~10µm section of face of same block prepared by laser ablation 
(Rowiak ‘TissueSurgeon’) viewed between crossed polars, showing continuity 
between lamellae in mineralised bone and osteoid. Field width = 141µm.  
Figure 3E. Same section, stained with MacNeal’s tetrachrome stain giving 
green-blue tint to osteoid. Field width = 900µm.  
Figure 3F. Same field stained with acridine red. Field width = 900µm.  
Figure 4, 5 parts, page width, ie, a ‘Plate’. 
Figure 4A.  Central part of shaft endosteum in a Tergazyme macerated KO 
femur. The dark patches are all abnormal osteoid (This scene is shown as a 3D 
anaglyph (red cyan)  image in Supplementary Fig 4A).  
Figure 4B. Endosteum in a Tergazyme macerated KO tibia. Dark osteoid 
surrounds blood vessel canals (white arrows) within an area showing a 
mineralising front with unfused mineralising centres.This is surrounded by 
resorption (labels Res)..  
Figure 4C. Endosteum in a Tergazyme macerated KO femur. Dark residual 
osteoid surrounds blood vessel canals (white arrows).  Individual canaliculi 
show as small black dots (too small to label) within the  unfused mineralising 
centres show. The fully mineralised back wall of a forming osteocyte lacuna 
lies near dead centre of image at point of black arrow.  
Figure 4D. Endosteum in a Tergazyme and H2O2 macerated KO femur. The 
additional treatment removes  residual osteoid from the endosteal surface and 
lining the blood vessel canals (black arrows). An area with abnormal 
mineralising front (outlined with white asterixes ‘*’) is surrounded by 
resorption (Res).  
Figure 4E. Endosteum in a Tergazyme and hydrogen peroxide macerated WT 
tibia at same scale, showing mostly a fully mineralised, smooth surface with 
some shallow resorbed patches (Res: one area outlined with white asterixes 
‘*’). The openings of the blood vessel canals (black arrows) show a fully 
mineralised surface. Surface osteocyte lacunae above labels ‘sol’. Some 
osteocyte lacunae are so superficial that their canaliculi lie in the plane of the 
fully mineralised (smooth) surface, showing as grey linear features in areas 
opposite points of white arrows. See also Supplementary Fig 4F. 
Figure 5, 4 parts, page width, ie, a ‘Plate’. 
Figure 5. KO endosteal surfaces  after further cleaning with NaOCl 
bleach to remove all organic matrix, importantly here, any osteoid. 
Figure 5A. KO tibia . Osteoclastic resorption (Res) has not proceeded into  
the abnormal mineralisation front area on an endosteal trabeculum.  
Figure 5B. KO tibia This is an area in which endosteal osteoclastic resorption 
(Res) has extended into bone with defective mineralisation surrounding blood 
vessel canal spaces (all the large dark features). There would have been 
osteoid evrywhere that we see unfused mineralised patches. 
Figure 5C. KO tibia, cut edge at top. This is an area in which endosteal 
osteoclastic resorption (Res) has extended into an endosteal osteoid patch 
(now removed by NaOCl ) analogous to the regions arrowed white in Fig 2B. 
It again shows defective mineralisation surrounding blood vessel canal spaces 
(the large dark features). 
Figure 5D. KO femur.  Unmineralised osteoid would certainly have been 
present over the right side of the field which shows unfused mineralised 
regions in which canaliculi can be seen as small dark features. The left side 
had been subject to osteoclastic resorption (Res). Note that the mineralisation 
of this region – at the border - appears to be complete, i.e., the bone was 
uniformly mineralised where mineralised.  
Figure 6, 2 parts, column width. 
Figure 6. Same field before and after etching  
Figure 6A. KO tibia, PMMA embedded ammonium tri-iodide stained to 
reveal soft tissue components, showing an osteoid patch at centre. Surface 
normal to electron beam. (All other SEM images in this MS were also 
recorded at normal electron beam incidence). 
Figure 6B. The same region after ‘DMG Icon-Etch’ HCl gel etching for 1 
min, followed by 5% NaOCl for 10 mins and ammonium tri-iodide staining. 
PMMA within the osteoid patch (os) is left proud after the combined etch 
treatment. Osteocyte lacunae also appear as ‘casts’ above the etched surface. 
Surface tilted at 33 degrees.  
Supplementary images and information 
Suppl Figure 4A, anaglyph version for viewing with red (left eye) and cyan 
(right eye) spectacles on a computer/monitor screen.  Central part of shaft 
endosteum in a Tergazyme macerated KO femur. The dark patches are all 
abnormal osteoid with unfused mineralising centres.  
Suppl Figure 4F. Tergazyme and hydrogen peroxide macerated WT femur 
showing endosteal surface with resorbed patches (Res) and fully mineralised 
(smooth) regions, one such outlined with white asterixes ‘*’. None of the 
changes found in KOs were seen in WTs. See also Figs 4D (KO) and Fig 4E 
(WT). 
Suppl Figure 4G & H show same field, Tergazyme macerated KO femur, 
endosteum. An abnormal mineralising front indicating arrested or impeded 
collagen-fibre-bundle centred  [NB NOT matrix vesicle centred!) is seen both 
at endosteal surfaces of the cortex and on trabeculae: this is indicative of 
osteomalacias in general. Focus in Suppl Fig 4G is on trabeculum in 
foreground and in Suppl Fig 4H is on endosteum in background.  
 
Post-maceration embedding. 
PMMA blocks of samples which had been previously macerated provided 
evidence that the maceration procedures had cleared out the cell contents of 
marrow spaces and blood vessel canals, but had left the abnormal osteoid in 
place. 
Suppl Figure 6C.  A Tergazyme and H2O2 macerated KO tibia was embedded 
in PMMA, the block surface polished and stained with ammonium triiodide 
solution. Methacrylate has filled the blood vessel canal spaces, including those 
within the abnormal osteoid patches (arrows), This proves that the maceration 
procedure did successfully removed cell remnants from within the blood 
vessel canal spaces.  
Suppl Figure 6D. Tergazyme and H2O2 macerated KO tibia embedded in 
PMMA in the fused growth plate region, showing unfused calcospherites 
within the calcified cartilage (Cs), which is normal, and the unfused  
mineralised regions within the osteoid (os), which is an abnormal 
phenomenon (osteomalacia).  
 
Suppl Figure 7. Sequence of XMT slices, every tenth slice = every 50µm 
horizontally, every 250µm vertically, showing distribution of osteoid patched 
within cortex from KO femur. Original slice numbers outside field at edges. 
 
Phospho1KO_XMT_movie.ppt or pptx or GIF 
Viewing XMT movies showing a series of cross sections is the best way to 
show the remarkable 3D extent of the totally non-mineralised regions.  
Same data set as Suppl Fig 7 but using every 5µm section in the range. 
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